Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
Tata Memorial Centre
Eligibility
Inclusion criteria
Inclusion criteria: All individuals above 18 years of age having histopathologically proven, recurrent and/or metastatic triple negative breast cancer (mTNBC) during the period of January 2015 to June 2022. Patients could have received any number of lines of treatment in the metastatic and/or recurrent setting.
Exclusion criteria
Exclusion criteria: Patients with breast cancer without triple negative disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the treatment pattern and outcomes in patients with recurrent unresectable and/or metastatic triple negative breast cancers.Timepoint: 24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the clinical and radiological profile in patients with metastatic TNBC.Timepoint: 24 months;To assess the patterns of treatment used in the management of recurrent and/or metastatic TNBC.Timepoint: 24 months;To assess the toxicity of treatment in included patients.Timepoint: 24 months;To evaluate the OS in patients with recurrent and/or metastatic TNBC who are treated at the Tata Memorial Hospital and/or ACTREC during the study period.Timepoint: 24 months;To evaluate the PFS in patients with recurrent and/or metastatic TNBC who receive chemotherapy and/or Immunotherapy Targeted therapy during the mentioned study period at the Tata Memorial Hospital and/or ACTREC.Timepoint: 24 months | — |
Countries
India
Contacts
Public ContactYogesh Kembhavi
Tata Memorial Centre
Outcome results
None listed